What Happened?
Shares of life sciences company Avantor (NYSE: AVTR) fell 15.5% in the morning session after the company reported disappointing second-quarter results and cut its full-year financial forecast. The company’s adjusted earnings per share of $0.24 missed analyst expectations, while revenue slipped 1% to $1.68 billion. Profitability saw a sharp decline as net income fell to $64.7 million from $92.9 million in the same quarter of the previous year. The company's Laboratory Solutions division, a key revenue source, recorded a 3% drop in sales. Compounding these issues, Avantor lowered its financial projections for the full year, signaling to investors that it anticipated these headwinds would continue. The combination of missing current earnings and lowering future guidance prompted the negative investor reaction.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Avantor? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Avantor’s shares are somewhat volatile and have had 12 moves greater than 5% over the last year. But moves this big are rare even for Avantor and indicate this news significantly impacted the market’s perception of the business.
The previous big move we wrote about was 11 days ago when the stock dropped 8% on the news that the company announced that it has appointed Emmanuel Ligner as its new President and Chief Executive Officer, effective August 18, 2025. Ligner will succeed Michael Stubblefield, whose departure was previously announced. The news of a leadership change, particularly one that brings in a CEO with no prior public company experience, appears to have created uncertainty among investors. Wolfe Research noted that while Ligner's extensive experience in bioprocessing is a strategic fit for Avantor, his lack of public company CEO experience might lead to investor scrutiny. The firm also highlighted that the absence of updated financial guidance alongside the announcement would likely "raise questions" for investors, who often react negatively to a lack of forward-looking statements during executive transitions.,.
Avantor is down 46.9% since the beginning of the year, and at $11.25 per share, it is trading 59.4% below its 52-week high of $27.70 from September 2024. Investors who bought $1,000 worth of Avantor’s shares 5 years ago would now be looking at an investment worth $501.78.
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
